BANK VONTOBEL/CALL/PFIZER INC/35/0.1/20.09.24 Share Price

Warrant

DE000VM3RDM5

Market Closed - Deutsche Boerse AG 19:02:57 27/06/2024 BST
0.006 EUR +50.00% Intraday chart for BANK VONTOBEL/CALL/PFIZER INC/35/0.1/20.09.24
1 month-66.67%
3 months-76.92%
Date Price Change
27/06/24 0.006 +50.00%
26/06/24 0.004 -20.00%
25/06/24 0.005 0.00%
24/06/24 0.005 -16.67%
21/06/24 0.006 0.00%

Delayed Quote Deutsche Boerse AG

Last update June 27, 2024 at 07:02 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying PFIZER, INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VM3RDM
ISINDE000VM3RDM5
Date issued 09/10/2023
Strike 35 $
Maturity 20/09/2024 (85 Days)
Parity 10 : 1
Emission price 0.25
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 0.29
Lowest since issue 0.004
Delta0.07x
Omega 15.42
Premium26.38x
Gearing207.77x
Moneyness 0.7943
Difference Strike 7.2 $
Difference Strike %+20.57%
Spread 0.015
Spread %75.00%
Intrinsic value 0.000000

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
27.8 USD
Average target price
31.92 USD
Spread / Average Target
+14.80%
Consensus